Matt Phillips's profile photo

Matt Phillips

New York

Senior Markets Correspondent at Sherwood News

Senior Markets Correspondent at Sherwood News. Ex-NYT, Axios, WSJ, QZ. Banjo/mando player. ❤️ ≠ ❤️. Opinions, vengeance mine. PGP: https://t.co/AzpENs86lx

Featured in: Favicon axios.com Favicon uol.com.br Favicon medium.com Favicon msn.com Favicon globo.com Favicon nytimes.com Favicon bloomberg.com Favicon reuters.com Favicon indiatimes.com (+1) Favicon independent.co.uk

Articles

  • 5 days ago | kplctv.com | Matt Phillips |Johnathan Manning

    VERNON PARISH, La. (KPLC) - A Texas woman has been arrested in connection with a crash that claimed the life of a 3-year-old in Vernon Parish three years ago. Amber Allison, 34, of Burkeville, is accused of letting Regina Shafer, 31, of Leesville, get behind the wheel prior to the fatal accident, according to court documents. Allison initially offered to drive the vehicle because Shafer was intoxicated, the court documents read.

  • 6 days ago | sherwood.news | Matt Phillips

    Net Q1 revenues at sports betting company DraftKings fell slightly short of Wall Street expectations in its report after the close Thursday. But it matched its bogey for earnings per share and investors seem to be giving DraftKings a pass, with shares up in early trading.

  • 6 days ago | sherwood.news | Matt Phillips

    Stocks slip slightly ahead of US and China trade negotiation talks over the weekendStocks were largely flat on Friday after President Trump said he may cut China’s 145% tariff to 80% ahead of trade negotiations in Switzerland this weekend. The S&P 500 slipped under 0.1%, the Nasdaq 100 ended flat, and the Russell 2000 fell 0.16%. Risk-on sectors like energy, real estate, and consumer discretionary outperformed, while healthcare, consumer staples, and communication services led the declines.

  • 6 days ago | sherwood.news | Matt Phillips

    Taser-maker Axon continued to bask in earnings afterglow Thursday. The stock was on track for a nearly 15% gain in the final hour of the session while collecting a rave review from equity analysts at Morgan Stanley. They upped their price target on the shares to $695 from $635, maintained their “overweight” rating, and called Axon’s nosebleed valuations warranted, given company’s track record of generating growth.

  • 1 week ago | sherwood.news | Matt Phillips

    Analysts at Citi raised their estimates and price target on Palantir, but they still won’t push the buy button. The reason, of course, is valuation, which has emerged as a sticking point for others, judging by the sharp sell-off the stock endured despite reporting results that were widely hailed on Wall Street as quite strong. In raising their target price from $110 to $115, Citi analysts concurred, as far as the numbers were concerned.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
18K
Tweets
15K
DMs Open
Yes
No Tweets found.